Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-15

Clinical Trial Update: CART-PSMA Cells for Advanced Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating CART-PSMA cell therapy for advanced prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CART-PSMA Cells (Chimeric antigen receptor T cells targeting PSMA)

Snippet

Sponsor: Nova Therapeutics LLC | Conditions: Prostate Cancer | Phase 1 | Status: RECRUITING